siRNA-mediated knockdown of VEGF-A, VEGF-C and VEGFR-3 suppresses the growth and metastasis of mouse bladder carcinoma in vivo

Stacher SA, Achen MG, Jussila L, Baldwin ME and Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2:573–583. 2002. View Article : Google Scholar

Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI

Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med. 9:669–676. 2003. View Article : Google Scholar : PubMed/NCBI

Saban MR, Towner R, Smith N, et al: Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer. 7:2192007. View Article : Google Scholar : PubMed/NCBI

Mylona E, Magkou C, Gorantonakis G, et al: Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder. Anticancer Res. 26:3567–3571. 2006.PubMed/NCBI

Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811. 1998. View Article : Google Scholar : PubMed/NCBI

Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 77:527–543. 1999. View Article : Google Scholar : PubMed/NCBI

Wang F, Wu JH, Tian YH, et al: Role of VEGF in the growth and metastasis of a murine bladder carcinoma. Chin Sci Bull. 48:2404–2410. 2003.

Joukov V, Pajusola K, Kaipainen A, et al: A novel vascular endothelial growth factor. VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290–298. 1996.

Oh SJ, Jeltsch MM, Birkenhäger R, et al: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol. 188:96–109. 1997. View Article : Google Scholar : PubMed/NCBI

Zu X, Tang Z, Li Y, Gao N, Ding J and Qi L: Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int. 98:1090–1093. 2006. View Article : Google Scholar : PubMed/NCBI

Hammond SM, Caudy AA and Hannon GJ: Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet. 2:110–119. 2001. View Article : Google Scholar : PubMed/NCBI

Devi GR: siRNA-based approaches in cancer therapy. Cancer Gene Ther. 13:819–829. 2006. View Article : Google Scholar : PubMed/NCBI

Karagiannis TC and El-Osta A: RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther. 12:787–795. 2005. View Article : Google Scholar : PubMed/NCBI

Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498. 2001. View Article : Google Scholar : PubMed/NCBI

Wang F, Tian YH, Chen XF and Huang Q: Microarray analysis the role of VEGF signaling pathway for the growth and metastasis of routine bladder earcinonla. Tumor. 27:847–885. 2007.

Sun P, Gao J, Liu YL, Wei LW, Wu LP and Liu ZY: RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells. Mol Cell Biochem. 308:161–168. 2008. View Article : Google Scholar

Jia RB, Zhang P, Zhou YX, et al: VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res. 39:108–115. 2007. View Article : Google Scholar : PubMed/NCBI

Guan H, Zhou Z, Wang H, Jia SF, Liu W and Kleinerman ES: A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing’s sarcoma growth in a xenograft mouse model. Clin Cancer Res. 11:2662–2669. 2005.PubMed/NCBI

Ioachim HLRH: Tumor-Reactive Lymphadenopathy. 3rd edition. Lippincott Williams and Wilkins; Philadelphia: pp. 254–258. 2002

Qian CN, Berghuis B, Tsarfaty G, et al: Preparing the ‘soil’: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 66:10365–10376. 2006.

Manoharan M: RNA interference and chemically modified small interfering RNAs. Curr Opin Chem Biol. 8:570–579. 2004. View Article : Google Scholar : PubMed/NCBI

Wang F, Chen XF, Tian YH, Wu JH, Li L, Li CY and Huang Q: Target gene transfer mediated by electroporation for cancer therapy in vivo. Prog Biochem Biophys. 29:734–740. 2002.